Wuhan General Group (China) Overview

  • Founded
  • 1988
Founded
  • Status
  • Public
  • Employees
  • 3
Employees
  • Stock Symbol
  • WUHN
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $0.34
  • (As of Thursday Closing)

Wuhan General Group (China) General Information

Description

M2Bio Sciences Inc, formerly Wuhan General Group (China) Inc is an alternative medicinal and botanicals company focused on the application of emerging technologies as well as the clinical research and health application of cannabidiol (CBD)-based medicine to the human and pet care industry for cancer, cardiovascular, mental disorders, chronic pain, and others in Canada, the United States, Europe, and Australia. It supplies medical grade CBD products, and superior patient care.

Contact Information

Website
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Machinery (B2B)
Other Industries
Electrical Equipment
Stock Exchange
PINX
Primary Office
  • Canglongdao Science Park of Wuhan
  • East Lake Hi-Tech Development Zone
  • Wuhan, Hubei 430200
  • China
+86 00000000000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Wuhan General Group (China) Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.34 $0.31 $0.02 - $0.42 244K

Wuhan General Group (China) Financials Summary

In Thousands,
USD
TTM 31-Dec-2012 FY 2012 31-Dec-2012 FY 2011 31-Dec-2011 FY 2010 31-Dec-2010
EV 101,338 101,338 77,183 99,738
Revenue 80,377 80,377 127,503 110,312
EBITDA 2,509 2,509 9,424 12,888
Net Income (10,590) (10,590) (3,860) 3,206
Total Assets 286,581 286,581 272,572 242,507
Total Debt 118,798 118,798 120,015 93,636
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Wuhan General Group (China) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Wuhan General Group (China)‘s full profile, request access.

Request a free trial

Wuhan General Group (China) Executive Team (4)

Name Title Board Seat Contact Info
Ramy Kamaneh President & Chief Executive Officer
Philip Lo Chief Financial Officer
Luka Marjanovic Executive
To view Wuhan General Group (China)’s complete executive team members history, request access »

Wuhan General Group (China) Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Wuhan General Group (China) Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00 0000000 04-Oct-2018 000000000000000000 Biotechnology 0000 0000000
To view Wuhan General Group (China)’s complete acquisitions history, request access »